参考文献/References:
[1] FUKAZAWA R,KOBAYASHI J,AYUSAWA M,et al. JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease[J].Circ J,2020,84(8): 1348-1407.
[2] 闫辉,杜军保.川崎病的临床诊治探索任重道远[J].中国实用儿科杂志,2017,32(8):561-564.
[3] 王雷,夏焙.超声心动图在川崎病诊断、治疗及长期随访中的应用进展——2017年AHA指南的解读[J/CD].中华医学超声杂志(电子版),2019,16(3):161-165.
[4] 中华医学会儿科学分会心血管病学组,《中华儿科杂志》编辑委员会.川崎病冠状动脉病变的临床处理建议(2020年修订版)[J].中华儿科杂志,2020,58(9):718-724.
[5] McCRINDLE B W,ROWLEY A H,NEWBURGER J W,et al. Diagnosis,treatment,and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association[J].Circulation,2017,135(17): e927-e999.
[6] DALLAIRE F,DAHDAH N. New equations and a critical appraisal of coronary artery Z scores in healthy children[J].J Am Soc Echocardiogr,2011,24(1): 60-74.
[7] YOKOTA S,KIKUCHI M,NOZAWA T,et al. Pathoge-nesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease,systemic onset juvenile idiopathic arthritis,and cryopyrin-associated periodic fever syndrome"[J].Modern Rheumatology,2015,25(1): 1-10.
[8] 范雪,徐明国.川崎病发病机制及治疗研究进展[J].中国实用儿科杂志,2021,36(5):339-344.
[9] 黄宏琳,黄育坤,林淑斌,等.TNF-α、IL-1β及IL-6 水平用于评估川崎病患儿发生冠状动脉损伤的临床价值[J].中国医学创新,2020,17(4):12-15.
[10] 彭珍,闫孝永.ACEF评分联合炎性因子评估小儿川崎病冠状动脉损害的临床价值[J].中西医结合心脑血管病杂志,2022,20(16):3016-3020.
[11] KIM M K,SONG M S,KIM G B. Factors predicting re-sistance to intravenous immunoglobulin treatment and coronary artery lesion in patients with Kawasaki disease:analysis of the Korean nationwide multicenter survey from 2012 to 2014[J].Korean Circ J,2018,48(1):71-79.
[12] RIFE E,GEDALIA A. Kawasaki disease: An update[J].Curr Rheumatol Rep,2020,22(10):75.
[13] SAMADLI S,LIU F F,MAMMADOV G,et al. The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease[J].Pediatr Rheumatol Online J,2019,17(1):53.
[14] 王远飞,李培岭,田运娇,等.川崎病合并中小型冠状动脉瘤持续时间危险因素分析[J].中华实用儿科临床杂志,2022,37(11): 816-820.
[15] 戈海延,曲东,刘霜,等. 6月龄以下婴儿川崎病冠状动脉病变的临床特征及预后分析[J].中国小儿急救医学,2022,29(3):206-210.